Abstract：Objective To investigate the effect of retrobulbar injection of Triamcinolone Acetonide in the treatment of ischemic optic neuropathy.Methods A total of 88 non arteritic anterior ischemic optic neuropathy （NAION）patients who were admitted to the First People′s Hospital of Nankang District from January to December 2019 were selected as the research objects.They were divided into control group and observation group by random number table method, with 44 cases in each group.The control group received Triamcinolone Acetonide injection next to the superficial temporal artery, and the observation group received Triamcinolone Acetonide injection after the ball.The clinical efficacy, visual recovery and adverse reactions were compared between the two groups.Results The total effective rate of treatment in the observation group was higher than that in the control group, and the difference was statistically significant (P<0.05).The visual acuity level before treatment between the two groups was not statistically significant (P>0.05).The visual field MS levels between the two groups of patients after treatment were higher than those before treatment, and the visual field MS level of observation group was higher than that of the control group, the differences were statistically significant (P<0.05).The best corrected visual acuity, retinal nerve fiber layer thickness, and intraocular pressure of the two groups after treatment were lower than those before treatment, and the intraocular pressure of observation group was lower than that of the control group, the differences were statistically significant (P<0.05).There was no statistically significance in total incidence of adverse reactions between the two groups (P>0.05).Conclusion The retrobulbar injection of Triamcinolone Acetonide in the treatment of NAION is safe and reliable, and can improve the vision of patients.
京公网安备 11010502046607号